Endovascular interventions for TransAtlantic InterSociety Consensus II C and D femoropopliteal lesions / 中华医学杂志(英文版)
Chinese Medical Journal
; (24): 415-420, 2013.
Article
在 En
| WPRIM
| ID: wpr-342570
Responsible library:
WPRO
ABSTRACT
<p><b>BACKGROUND</b>Peripheral artery disease accounts for more than 400 000 hospitalizations in the USA and results in symptoms ranging from claudication to gangrene. Recent advances in endovascular techniques have led to a more aggressive approach for treating peripheral artery disease. The aim of this retrospective study was to evaluate the outcomes of endovascular interventions on TransAtlantic InterSociety Consensus (TASC) II C and D femoropopliteal occlusive disease.</p><p><b>METHODS</b>Data for all patients undergoing endovascular interventions for femoropopliteal occlusive disease from December 2007 through December 2010 were reviewed. Demographic data, risk factor data, preprocedural and postprocedural ankle-brachial indices, technical success rates, and complication rates were obtained. Primary, assisted primary, and secondary patency were determined by Kaplan-Meier survival analysis. Univariate and multivariate analyses were performed to identify factors adversely affecting primary patency.</p><p><b>RESULTS</b>The study group included 52 TASC II C and 106 TASC II D limbs in 126 patients (mean age, (68.0 ± 18.0) years). The technical success rate was 91.1%. Complications occurred in 19 limbs (12.0%), including 8 (5.1%) major complications. The mean follow-up period was (17.6 ± 5.1) months (range, 12.0 - 48.0 months). Primary patency rates at 1, 2, 3, and 4 years were 95%, 78%, 74%, and 74% in TASC II C lesions and 89%, 62%, 52%, and 52% in TASC II D lesions, respectively. Secondary patency rates at 1, 2, 3, and 4 years were 97%, 94%, 94%, and 94% in TASC II C lesions and 97%, 95%, 83%, and 83% in TASC II D lesions, respectively. It is significantly different between primary patency rates (P < 0.05) but not secondary patency rates of TASC II C and D groups (P > 0.05). Predictors of restenosis/occlusion included hyperlipidemia, lesion length, and popliteal artery involvement.</p><p><b>CONCLUSIONS</b>Endovascular treatment of TASC II C and D femoropopliteal artery occlusion has a high technical success rate with favorable mid-term secondary patency rate. Hyperlipidemia, lesion length, and popliteal artery involvement were independent risk factors for in-stent restenosis.</p>
全文:
1
索引:
WPRIM
主要主题:
Popliteal Artery
/
Arterial Occlusive Diseases
/
General Surgery
/
Retrospective Studies
/
Femoral Artery
/
Endovascular Procedures
/
Methods
研究类型:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
限制:
Female
/
Humans
/
Male
语言:
En
期刊:
Chinese Medical Journal
年:
2013
类型:
Article